Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection

AIDS Reviews

Volumn 13, Issue 3, 2011, Pages 171-179

  Gallego, Lucía ^a   Barreiro, Pablo ^b   Lopéz Ibor, Juan José ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

HIV; Neurocognitive disorders; Psychiatric disorders; Substance abuse

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; ILLICIT DRUG; INDINAVIR; KETAMINE; LAMIVUDINE; LOPINAVIR; LYSERGIDE; MARAVIROC; NEVIRAPINE; PROTEINASE INHIBITOR; RALTEGRAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; VICRIVIROC; ZIDOVUDINE;

ACUTE STRESS DISORDER; ADJUSTMENT DISORDER; ALCOHOLISM; ANTISOCIAL BEHAVIOR; ANXIETY DISORDER; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BORDERLINE STATE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID; COGNITIVE DEFECT; COMORBIDITY; CRITICALLY ILL PATIENT; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DEPENDENCE; ERECTILE DYSFUNCTION; HEALTH BEHAVIOR; HISTRIONIC PERSONALITY DISORDER; HIV ASSOCIATED DEMENTIA; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPULSIVENESS; MAJOR DEPRESSION; MANIA; MEMORY DISORDER; MOOD DISORDER; NEUROLOGIC EXAMINATION; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PERSONALITY DISORDER; PHARMACOKINETICS; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SUBSTANCE ABUSE;

AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 80755148800     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Meade C, Sikkema K. HIV risk behavior among adults with severe mental illness: systematic review. Clin Psychol Rev. 2005;25:433-57. (Pubitemid 40731527)
2. Crosby G, Stall R, Paul J, Barrett D. Substance use and HIV risk profile of gay/bisexual males who drop out of substance abuse treatment. AIDS Educ Prev. 2000;12:38-48. (Pubitemid 30155342)
3. Stall R, Paul J, Barrett D, Crosby G, Bein E. An outcome evaluation to measure changes in sexual risk-taking among gay men undergoing substance use disorder treatment. J Stud Alcohol. 1999;60:837-45. (Pubitemid 29526550)
4. Chesney M, Barrett D, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health. 1998;88:113-16. (Pubitemid 28109654)
5. Bing E, Kilbourne A, Brooks R, Senak M. Factors affecting use of protease inhibitors among a community sample of people with HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:474-80. (Pubitemid 29198287)
6. Lyketsos C, Hutton H, Fishman M, Schwarz J, Treisman G. Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996;10: 1033-9. (Pubitemid 26252635)
7. Practice guideline for the treatment of patients with HIV/AIDS. Work Group on HIV/AIDS. American Psychiatric Association. Am J Psychiatry. 2000;157:1-62.
8. Olley B, Seedat S, Nei D, Stein D. Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS. 2004;8:481-7. (Pubitemid 39129278)
9. Grassi L, Righi R, Sighinolfi L, Makoui S, Ghinelli F. Coping styles and psychosocial-related variables in HIV-infected patients. Psychosomatics. 1998;39:350-9. (Pubitemid 28347785)
10. Namir S, Wolcott D, Fawzy F, et al. Coping with AIDS: psychological and health implications. J Appl Soc Psychol. 1987;17:309-28.
11. Wolf T, Balson P, Morse E, et al. Relationship of coping style to affective state and perceived social support in asymptomatic and symptomatic HIV-infected persons: implications for clinical management. J Clin Psychiatry. 1991;52:171-3.
12. Nicholson W, Long B. Self-esteem, social support, internalized homophobia, and coping strategies of HIV+ gay men. J Consult Clin Psychol. 1990;58:873-6.
13. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti J: APROCO cohort study group. Adherence to HAART in HIV infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54:1481-96.
14. Bartlett J. Addressing the challenges of adherence. J Acquir Immune Defic Synd. 2002;29(Suppl 1):S-S0.
15. Ferrando SJ, Wall TL, Batki SL, Sorensen JL. Psychiatric morbidity, illicit drug use and adherence to ZDV among injection drug users with HIV disease. Am J Drug Alcohol Abuse. 1996;22:475-87. (Pubitemid 26361020)
16. Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS. 1999;13(Suppl A):271-8.
17. Gordillo V, Del Amo J, Soriano, V, González-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-9. (Pubitemid 30015725)
18. Singh N, Berman S, Swindells S, et al. Adherence of HIV-infected patients to antiretroviral therapy. Clin Infect Dis. 1999;29:824-30. (Pubitemid 30256376)
19. Evans S, Ferrando S, Sewell M, et al. Pain and depression in HIV illness. Psychosomatics. 1998;39:528-35. (Pubitemid 28515878)
20. Holmes W, Bix B, Meritz M, et al. HIV and quality of life: the potential impact of axis I psychiatric disorders in a sample of 95 HIV seropositive men. Psychosomatic Med. 1997;59:187-92. (Pubitemid 27143489)
21. Sherbourne C, Hays R, Fleishman J, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248-54. (Pubitemid 30080906)
22. Piette J, Fleishman J, Stein M, Mor V, Mayer K. Perceived needs and unmet needs for formal services among people with HIV disease. J Community Health. 1993;18:11-23. (Pubitemid 23121407)
23. Belcher J. Are jails replacing the mental health system for the homeless mentally ill? Community Ment Health J. 1988;24:185-95.
24. Hopper K, Jost J, Hay T, Welber S, Haugland G. Homelessness, severe mental illness, and the institutional circuit. Psychiatr Serv. 1997;48:659-65. (Pubitemid 27208567)
25. DuPont R, Rice D, Miller L, Shiraki S, Rowland C, Harwood H. Economic costs of anxiety. Anxiety. 1996;2:167-72.
26. French M, Mauskopf J, Teague J, Roland E. Estimating the dollar value of health outcomes from drug abuse interventions. Med Care. 1996;34:890-910. (Pubitemid 126465548)
27. Rice D, Kelman S, Miller L. The economic burden of mental illness. Hosp Community Psychiatry. 1992;43:1227-32.
28. Mayne T, Vittinghoff E, Chesney M, et al. Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med. 1996;156:2233-8. (Pubitemid 26361917)
29. Cohen M, Goforth H, Lux J, Batista S, Cozza K, Khalife S. Handbook of AIDS Psychiatry. Oxford University Press, 2010.
30. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition Text Revision American Psychiatric Association. Washington, DC, 1994.
31. Leopold K, Ahles T, Walch S, et al. Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy. Int J Radiat Oncol Biol Phys. 1998;42:1105-12. (Pubitemid 29004155)
32. Ford S, Lewis S, Fallowfield L. Psychological morbidity in newly referred patients with cancer. J Psychosom Res. 1995;39:193-202.
33. Wells K, Golding J, Burnam M. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988;145:976-81.
34. Regier D, Boyd J, Burke J, et al. One month prevalence of mental disorders in the United States. Arch Gen Psychiatry. 1988;45:977-86.
35. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12- month prevalence of DSM-III-R Psychiatric disorders in the United States. Arch Gen Psychiatry. 1994;51:8-19.
36. Bing E, Burnham M, Longshore D, et al. Psychiatric disorders and drug use among HIV-infected adults in the United States. Arch Gen Psychiatry. 2001;58:721-8. (Pubitemid 32717795)
37. Evans D, Charney D. Mood disorders and medical illness: a major public health problem. Biol Psychiatry. 2003;54:177-80. (Pubitemid 37267845)
38. Galvan F, Burnam M, Bing E. Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV+ people. J Psychoactive Drugs. 2003;35(Suppl 1):153-60. (Pubitemid 36676105)
39. Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: a critical review. Clin Psychol Rev. 1997;17:259-69. (Pubitemid 27221017)
40. Brown G, Rundell J, McManis S, et al. Prevalence of psychiatric disorder in early stages of HIV infection. Psychosom Med. 1992;54:588-601.
41. Kelly B, Raphael B, Judd F, et al. Psychiatric disorder in HIV infection. Aust N Z J Psychiatry. 1998;32:441-53. (Pubitemid 28306368)
42. Maj M, Janssen R, Starace F, et al. WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry. 1994;51:39-49. (Pubitemid 24028997)
43. Williams J, Rabkin J, Remien R, et al. Multidisciplinary baseline assessment of homosexual men with and without HIV infection: standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry. 1991;48:124-30.
44. Chuang H, Jason G, Pajurkova E, et al. Psychiatric morbidity in patients with HIV infection. Can J Psychiatry. 1992;37:109-15.
45. Gallego L, Gordillo V, Catalan J. Psychiatric and Psychological Disorders associated to HIV Infection. AIDS Rev. 2000;2:48-59. (Pubitemid 30479321)
46. Uldall K, Harris V, Lalonde B: Outcomes associated with delirium in acutely hospitalized AIDS patients. Compr Psychiatry. 2000;41:88-91. (Pubitemid 30149016)
47. Uldall K, Ryan R, Berghuis J, Harris V. Association between delirium and death in AIDS patients. AIDS Patient Care STDS. 2000;14:95-100. (Pubitemid 30126950)
48. nd Edition). Johnson R (Ed.). Lippincott-Raven, PA, USA, 1998;287-313.
49. Becker J, Caldarado R, López O, Dew M, Dorst S, Banks G. Qualitative features of the memory deficit associated with HIV infection and AIDS: Cross-validation of a discriminant function classification scheme. J Clin Exp Neuropsychol. 1995;17:134-42.
50. Miller E, Selnes O, McArthur J, et al. Neuropsychological performance in HIV-1 Infected homosexual men: The multicenter AIDS Cohort Study (MACS). Neurology. 1990;40:197-203. (Pubitemid 20099421)
51. Peavy G, Jacobs D, Salmon D, et al. The HNRC Group: Verbal memory performance of patients with HIV infection: Evidence of subcortical dysfunction. J Clin Exp Neuropsychol. 1994;16:508-23. (Pubitemid 24228963)
52. Rottenberg D, Moeller J, Strother S, et al. The metabolic pathway of the AIDS dementia complex. Ann Neurol. 1987;22:700-6. (Pubitemid 18018465)
53. Dawes S, Suarez P, Casey C, et al. Variable patterns of neuropsychological performance in HIV-1 infection. J Clin Exp Neuropsychol. 2008; 30:613-26. (Pubitemid 351957691)
54. Grant I, Atkinson J, Hesselink J, et al. Evidence for early central nervous system involvement in AIDS and other HIV infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987;107:828-36. (Pubitemid 18014233)
55. Heaton R, Grant I, Butters N, et al. The HNRC 500óneuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J Int Neuropsychol Soc. 1995;1:231-51.
56. Power C, Boisse L, Rourke S, Gill M. NeuroAIDS: an evolving epidemic. Can J Neurol Sci. 2009;36:285-95.
57. Navia B, Jordan B, Price R. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986;19:517-24. (Pubitemid 16085185)
58. Klunder A, Chiang M, Dutton R, et al. Mapping cerebellar degeneration in HIV/AIDS. Neuroreport. 2008;19:1655-9.
59. Cole M, Castellon S, Perkins A, et al. Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. J Int Neuropsychol Soc. 2007;13:549-54. (Pubitemid 47307496)
60. Nomenclature and research case definitions for neurologic manifestations of HIV-1 infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41:778-85.
61. Antinori A, Arendt G, Becker J, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789-99. (Pubitemid 350059308)
62. Robertson K, Smurzynski M, Parsons T, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007;21:1915-21. (Pubitemid 47329768)
63. McArthur J, Hoover D, Bacellar H. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245-52. (Pubitemid 23346956)
64. Bhaskaran K, Mussini C, Antinori A, et al. Changes in the incidence and predictors of HIV-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63:213-21. (Pubitemid 351355300)
65. Letendre S, Marquie-Beck J, Capparelli E, et al. CHARTER Group. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65:65-70.
66. Wright E. Neurocognitive impairment and neuroCART. Curr Opin HIV AIDS. 2011;6:303-8.
67. Letendre S, Ellis R, Ances B, McCutchan J. Neurologic complications of HIV disease and their treatment. Top HIV Med. 2010;18:45-55.
68. Martin-Thormeyer E, Paul R. Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features. Neuropsychol Rev. 2009;19:215-31.
69. Wright E, Grund B, Robertson K, et al. INSIGHT SMART Study Group. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology. 2010;75:864-73.
70. Ghafouri M, Amini S, Khalili K, Sawaya B. HIV-1 associated dementia: symptoms and causes. Retrovirology. 2006;3:28.
71. Scott J, Woods S, Matt G, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007;17:275-97. (Pubitemid 47498174)
72. Nath A. HIV-associated neurocognitive disorder: pathophysiology in relation to drug addiction. Ann N Y Acad Sci. 2010;1187:122-8.
73. Clark U, Cohen R. Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals. Curr Opin Investig Drugs. 2010;11:884-900.
74. Sevigny J, Albert S, McDermott M, et al. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol. 2007;64:97-102. (Pubitemid 46072430)
75. Tozzi V, Balestra P, Bellagamba R, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007;45:174-82. (Pubitemid 46869810)
76. Atkinson J, Grant I. Natural history of neuropsychiatric manifestations of HIV disease. Psych Clin North America. 1994;17:17-33. (Pubitemid 24132875)
77. Heaton R, Marcotte T, Mindt M, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004;10:317-31. (Pubitemid 38779804)
78. Heaton R, Velin R, McCutchan J, et al. Neuropsychological impairment in HIV infection: implications for employment HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med. 1994;56:8-17.
79. Marcotte T, Lazzaretto D, Scott J, Roberts E, Woods S, Letendre S. Visual attention deficits are associated with driving accidents in cognitively- impaired HIV-infected individuals. J Clin Exp Neuropsychol. 2006;28:13-28. (Pubitemid 43207237)
80. Woods S, Dawson M, Weber E, Gibson S, Grant I, Atkinson J. Timing is everything: antiretroviral non-adherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc. 2009;15:42-52.
81. Hinkin C, Hardy D, Mason K, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status and substance. AIDS. 2004;18:19-25.
82. Stevens P, Tighe Doerr B. Trauma of discovery: women's narratives of being informed they are HIV-infected. AIDS Care. 1997;9:523-38. (Pubitemid 27462303)
83. Catalan J, Burgess A, Klimes I. Psychological Medicine of HIV Infection. Oxford: Oxford University Press, 1995.
84. Kalichman S. Understanding AIDS: Advances in research and treatment (2nd ed.). Washington, DC, US: American Psychological Association, 1998.
85. Rosenberger P, Bornstein R, Nasrallah H, et al. Psychopathology in HIV: lifetime and current assessment. Compr Psychiatry. 1993;34:150-8.
86. Lipsitz J, Williams J, Rabkin J, et al. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry. 1994;151:1662-8. (Pubitemid 24337601)
87. Nebhinani N, Mattoo S, Wanchu A. Psychiatric morbidity in HIV-positive subjects: a study from India. J Psychosom Res. 2011;70:449-54.
88. Dilley J, Ochitill H, Perl M, Volderbing P. Findings in psychiatric consultations with patients with AIDS. Am J Psychiatry. 1985;142:82-6.
89. Gala C, Pergami A, Catalan J, et al. The psychosocial impact of HIV infection in gay men, drug users and heterosexuals: controlled investigation. Br J Psychiatry. 1993;163:651-9. (Pubitemid 23325384)
90. Johnson J, Williams J, Rabkin J, et al. Axis I psychiatric symptomatology associated with HIV infection and personality disorder. Am J Psychiatry. 1995;152:551-4.
91. Dew M, Becker J, Sánchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27:395-409. (Pubitemid 27139972)
92. Myers H, Durvasula R. Psychiatric disorders in African American men and women living with HIV/AIDS. Cult Div Ethn Min Psychol. 1999;5:249-62. (Pubitemid 29382089)
93. Sewell MC, Goggin KJ, Rabkin JG, Ferrando SJ, McElhiney MC, Evans S. Anxiety syndromes and symptoms among men with AIDS: a longitudinal controlled study. Psychosomatics. 2000;41:294-300. (Pubitemid 30439807)
94. Barroso J, Hammill B, Leserman J, Salahuddin N, Harmon J, Pence B. Physiological and psychosocial factors that predict HIV-related fatigue. AIDS Behav. 2010;14:1415-27.
95. Lyketsos C, Hoover D, Guccione M, et al. Changes in depressive symptoms as AIDS develops: The Multicenter AIDS Cohort Study. Am J Psychiatry. 1996;153:1430-7. (Pubitemid 26365457)
96. Ceisla J, Roberts J. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158: 725-30. (Pubitemid 32429839)
97. Morrison M, Petitto J, Ten Have T, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002;159:5789-96.
98. Wagner G. Predictors of antiretroviral adherence as measured by self report, electronic monitoring and medication diaries. AIDS Patient Care STDS. 2002;16:599-608. (Pubitemid 36008059)
99. Schonnesson L, Williams M, Ross M, Bratt G, Deel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule and dietary instructions. AIDS Behav. 2007;11:175-83.
100. Kelly J, Murphy D, Bahr G, et al. Factors associated with severity of depression and high risk sexual behavior among persons diagnosed with HIV infection. Health Psychol. 1993;12:215-19.
101. Ammassari A, Antinori A, Aloisi M, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004; 45:394-402. (Pubitemid 39166911)
102. Hartzell J, Janke I, Weintrob A. Impact of depression on HIV outcomes in the HAART era. J Antimicrob Chemother. 2008;62:246-55. (Pubitemid 351984767)
103. Cook J, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-40. (Pubitemid 38857313)
104. Bouhnik A, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10:53-61. (Pubitemid 40767631)
105. Ironson G, O'Cleirigh C, Fletcher M, et al. Psychosocial factors predict CD4 and viral load change in men and women with HIV in the era of highly active antiretroviral treatment. Psychosom Med. 2005;67: 1013-21. (Pubitemid 43740117)
106. Ickovics J, Hamburger M, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466-74. (Pubitemid 32221895)
107. Kelly B, Raphael B, Judd F, et al. Suicidal ideation, suicide attempts, and HIV infection. Psychosomatics. 1998;39:405-15. (Pubitemid 28439940)
108. Komiti A, Judd F, Grech P, et al. Suicidal behaviour in people with HIV/ AIDS: a review. Aust N Z J Psychiatry. 2001;35:747-57. (Pubitemid 34048445)
109. Aldaz P, Moreno-Iribas C, Egüés N, et al. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health. 2011;11:300.
110. Gala C, Pergami A, Catalan J, et al. Risk of deliberate self-harm and factors associated with suicidal behaviour among asymptomatic individuals with HIV infection. Acta Psychiatr Scand. 1992;86:70-5.
111. Keiser O, Spoerri A, Brinkhof M, et al. Swiss National Cohort. Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. Am J Psychiatry. 2010;167:143-50.
112. Carrico A. Elevated suicide rate among HIV-positive persons despite benefits of antiretroviral therapy: implications for a stress and coping model of suicide. Am J Psychiatry. 2010;167:117-19.
113. Haller D, Miles D. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of life. AIDS Behav. 2003;7:101-8. (Pubitemid 36781505)
114. Lyketsos C, Hanson A, Fishman M, Rosenblatt A, McHugh P, Treisman G. Manic syndrome early and late in the course of HIV. Am J Psychiatry. 1993;150:326-7. (Pubitemid 23046524)
115. Nakimuli-Mpungu E, Musisi S, Mpungu S, Katabira E. Clinical presentation of bipolar mania in HIV-positive patients in Uganda. Psychosomatics. 2009;50:325-30.
116. Angelino A, Treisman G. Issues in co-morbid severe mental illnesses in HIV infected individuals. Int Rev Psychiatry. 2008;20:95-101. (Pubitemid 351196204)
117. Halman M, Bialer P, Worth J, Rourke S. HIV disease/AIDS. In: The American Psychiatric Publishing Textbook of Consultation-Liaison Psychiatry: Psychiatry in the Medically Ill. Edited by Wise M, Rundell J. Washington, DC, American Psychiatric Publishing, 2002;825-6.
118. Ellen S, Judd F, Mijch A, et al. Secondary mania in patients with HIV infection. Aust N Z J Psychiatry. 1999;33:353-60. (Pubitemid 29312794)
119. Mijch A, Judd F, Lyketsos C, et al. Secondary mania in patients with HIV infection: are antiretrovirals protective?. J Neuropsychiatry Clin Neurosci. 1999;11:475-80.
120. Chander G, Josephs J, Fleishman J, et al. Alcohol use among HIV-infected persons in care: results of a multisite survey. HIV Med. 2008;9:196-202. (Pubitemid 351467791)
121. Disney E, Kidorf M, Kolodner K, et al. Psychiatric comorbidity is associated with drug use and HIV risk syringe exchange participants. J Nerv Ment Dis. 2006;194:577-83.
122. Forrest D, Metsch L, LaLota M, Cardenas G, Beck D, Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health. 2010;87:480-5.
123. Van Tieu H, Koblin B. HIV, alcohol, and noninjection drug use. Curr Opin HIV AIDS. 2009;4:314-8.
124. Hendershot C, Stoner S, George W, Norris J. Alcohol use, expectancies, and sexual sensation seeking as correlates of HIV risk behavior in heterosexual young adults. Psychol Addict Behav. 2007;21:365-72. (Pubitemid 47488763)
125. Zule W, Costenbader E, Commers C, et al. Stimulant use and sexual risk behaviors for HIV in rural North Carolina. J Rural Health. 2007;23:73-8.
126. Samet J, Walley A, Bridden C. Illicit drugs, alcohol and addiction in HIV. Panminerva Med. 2007;49:67-77.
127. Baum M, Rafie C, Lai S, Sales S, Page J, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26:511-8.
128. Green J, Saveanu R, Bornstein R. The effect of previous alcohol abuse on cognitive function in HIV infection. Am J Psychiatry. 2004; 161:249-54. (Pubitemid 38419275)
129. Bruce R, Altice F, Friedland G. Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: implications and management for clinical practice. Exp Rev Clin Pharm. 2008; 1:115-27.
130. Kresina T, Flexner C, Sinclair J, et al. Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses. 2002;18:757-70.
131. Flexner C, Cargill V, Sinclair J, Kresina T, Cheever L. Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy. AIDS Patient Care STDS. 2001;15:57-8. (Pubitemid 32164605)
132. McDowell J, Chittick G, Stevens C, Edwards K, Stein D. Pharmacokinetic interaction of abacavir (1592U89) and ethanol in HIV-infected adults. Antimicrob Agents Chemother. 2000;44:1686-90. (Pubitemid 30340815)
133. Brück S, Witte S, Brust J, et al. Hepatotoxicity in patients prescribed efavirenz or nevirapine. Eur J Med Res. 2008;13:343-8.
134. Antoniou T, Tseng A. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother. 2002;36:598-613.
135. Goggin K, Engelson E, Rabkin J. The relationship of mood, endocrine and sexual disorders in HIV+ women: an exploratory study. Psychosom Med. 1998;60:11-6. (Pubitemid 28124830)
136. Newshan G, Taylor B, Gold R. Sexual functioning in ambulatory men with HIV/AIDS. Int J STD AIDS. 1998;9:672-6. (Pubitemid 28537776)
137. Rosser B, Metz M, Bockting W, et al. Sexual difficulties, concerns and satisfaction in homosexual men: an empirical study with implications for HIV prevention. J Sex Marital Ther. 1997;23:61-73. (Pubitemid 27133561)
138. Shindel A, Horberg M, Smith J, Breyer B. Sexual Dysfunction, HIV, and AIDS in Men Who Have Sex with Men. AIDS Patient Care STD. 2011;25:41-9.
139. Tubino M, Abdo C. Sexual dysfunctions among people living with AIDS in Brazil. Clinics (Sao Paulo). 2010;65:511-19.
140. De Ronchi D, Faranca I, Forti P, et al. Development of acute psychotic disorders and HIV-1 infection. Int J Psychiatry Med. 2000;30:173-83.
141. Walkup J, Crystal S, Sambamoorthi U. Schizophrenia and major affective disorder among Medicaid recipients with HIV/AIDS in New Jersey. Am J Public Health. 1999;89:1101-3. (Pubitemid 30433953)
142. Sewell D. Schizophrenia and HIV. Schizophr Bull. 1996;22:465-73. (Pubitemid 26295349)
143. Catalan J, Ho B. HIV-1 associated psychotic disorders. Clin Neuropharmacol. 1992;15(Suppl 1):368-9.
144. Perkins D, Davison E, Leserman J. Personality disorder in patients with HIV: a controlled study with implications for clinical care. Am J Psychiatry. 1993;150:309-15. (Pubitemid 23046520)
145. Jacobsberg L, Frances A, Perry S. Axis II diagnoses among volunteers for HIV testing and counselling. Am J Psychiatry. 1995;152:1222-4.
146. Golding M, Perkins D. Personality disorder in HIV Infection. Int Rev Psychiatry. 1996;8:253-8. (Pubitemid 26355474)
147. Hansen N, Vaughan E, Cavanaugh C, Connell C, Sikkema K. Health-related quality of life in bereaved HIV-positive adults: relationships between HIV symptoms, grief, social support, and Axis II indication. Health Psychol. 2009;28:249-57.
148. Reid S, Dwyer J. Insomnia in HIV infection: a systematic review of prevalence, correlates, and management. Psychosom Med. 2005;67:260-9. (Pubitemid 40410962)
149. Rubinstein M, Selwyn P. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:260-5.
150. Nokes K, Kendrew J. Correlates of sleep quality in persons with HIV disease. J Assoc Nurses AIDS Care. 2001;12:17-22.
151. Darko D, McCutchan J, Kripke D, et al. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry. 1992;149:514-20.
152. Gallego L, Barreiro P, del Río R, et al. Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz. Clin Infect Dis. 2004;38:430-2. (Pubitemid 38200124)
153. Norman S, Chediak A, Freeman C, et al. Sleep disturbances in men with asymptomatic HIV infection. Sleep. 1992;15:150-5.
154. Drake R, Mercer-McFadden C, Mueser K, et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998;24:589-608. (Pubitemid 28524628)
155. Moggi F, Hirsbrunner H, Brodbeck J, Bachmann K. One-year outcome of an integrative inpatient treatment for dual diagnosis patients. Addict Behav. 1999;24:589-92. (Pubitemid 29342938)
156. Sylvestre D, Loftis J, Hauser P, et al. Co-occurring hepatitis C, substance use and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health. 2004;81:719-34. (Pubitemid 39457952)
157. Ghebremichael M, Paintsil E, Ickovics J, et al. Longitudinal association of alcohol use with HIV disease progression and psychological health of women with HIV. AIDS Care. 2009;21:834-41.
158. Douaihy A, Jou R, Gorske T, Salloum I. Triple Diagnosis: Dual Diagnosis and HIV Disease, Part 1. AIDS Read. 2003;13:7.
159. Silberstein C, Galanter M, Marmor M, et al. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse. 1994;20:101-13. (Pubitemid 24074380)